Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-084902
Filing Date
2016-11-04
Accepted
2016-11-04 16:14:44
Documents
80
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2016 form10q.htm 10-Q 719521
2 EXHIBIT 10.2 ex10_2.htm EX-10.2 118686
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 11469
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 10656
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6584
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 6504
  Complete submission text file 0001140361-16-084902.txt   5771727

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rnn-20160930.xml EX-101.INS 1509907
8 XBRL TAXONOMY EXTENSION SCHEMA rnn-20160930.xsd EX-101.SCH 59101
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20160930_cal.xml EX-101.CAL 47903
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20160930_def.xml EX-101.DEF 129323
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20160930_lab.xml EX-101.LAB 366933
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20160930_pre.xml EX-101.PRE 304545
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 161975323
SIC: 2834 Pharmaceutical Preparations